בריטברד

לפרטים על תואר ראשון ושני

למידע נוסף על לימודים אקדמיים בלבד השאירו פרטיכם ונחזור בהקדם

ראשי » בריטברד
ד"ר בריטברד אורי ,
  • בתיאום מראש

Curriculum Vitae
קורות חיים

Education

השכלה

2006- 2010                Post Doctoral fellow, Dept. of  Cell and Developmental Biology,
                                   Alexander Silberman Institute of Life Sciences, 
                                   The Hebrew University of Jerusalem, Israel.
                                   Supervisor: Prof. Jacob Hochman
                                   Research interests:  
                                   1. Developing novel approaches toward reversal of multi-drug resistance in
                                    cancer.  
                                  2.Vaccination against breast cancer.

2001- 2005                 Ph.D. , Dept. of  Biological Chemistry, Alexander Silberman Institute of Life Sciences,
                                    The Hebrew University of Jerusalem, Israel.
                                    Supervisors: Prof. Wilfred D. Stein and prof. Deborah Rund.
                                    Research Title:  
                                    Characterization of proteins that are involved in resistance
                                     to chemotherapy in different kinds of leukemia

1999-2000                  M.Sc. , Dept. of  Biological Chemistry, Alexander Silberman Institute of Life Sciences,
                                    The Hebrew University of Jerusalem, Israel.
                                    Supervisor: Prof. Wilfred D. Stein
                                    Thesis Title: Methods to estimate the amount and cost of production of
                                    P-glycoprotein from different sources of membranes.

1996-99                       B.Sc. Degree in Biology, Faculty of Life Sciences, 
                                    Bar Ilan University, Ramat Gan, Israel.

1992-95                      Senior Teacher Degree in Bible and Gmara, 
                                    The E.M. Liphshitz Religious Teachers College
                                    Kiryat Shmona (the northern branch), Israel.

 

Work Experience

ניסיון עבודה

2010—present            Research  Associate –The  Institute of Chemistry and the  Dept. of  Cell and
                                   Developmental Biology, Alexander Silberman Institute of Life Sciences,
                                   The Hebrew University of Jerusalem, Israel.
                                    Research interests:
                                    1. Ti(IV) Complexes for Biological Applications (with Prof. Edit Y. Tshuva - Institute of 
                                    Chemistry) .
                                    2. Developing novel approaches toward reversal of multi-drug resistance in cancer. 
                                    3.Vaccination against breast cancer
                                      (with Prof. Jacob Hochman- Dept. of Cell and Developmental Biology ) .

2000-present              lecturer in Biochemistry, physiology of the cell, physiology of human
                                   systems and structural biology. Dept. of Bioinformation,
                                   Jerusalem College of Technology, Jerusalem  ,Israel.

2006- 2010                  Senior ScientistImmune System Key ltd.

1999-2006                   Researcher  - MDR Tests ltd.

 

Publications

פרסומים

1. The Signal Peptide of Mouse Mammary Tumor Virus-Env: A Phosphoprotein Tumor Modulator

Feldman, D., Roniger, M., Bar-Sinai, A., Braitbard, O., Rajchman, D., Natan, c., Love, D. C., Hanover, J. A. and Hochman,  Molecular Cancer Research  2012.

2. Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates.

Wellhöner H, Weiss A, Schulz A, Adermann K, Braitbard O, Bar-Sinai A, Hochman J. J Drug Target. 2012 Jun;20(5):445-52.

3. Highly cytotoxic vanadium(V) complexes of salan ligands; insights on the role of hydrolysis.

Reytman L, Braitbard O, Tshuva EY. Dalton Trans. 2012 May 7;41(17):5241-7.

4. Salan-Ti(IV) Complexes are Highly Robust and Highly Active Towards A Range of Sensitive and Drug Resistant Cell Lines

Cesar M. Manna, Ori Braitbard, Esther Weiss-Lavi, Jacob Hochman, and Edit Y. Tshuva . ChemMedChem.  2012 Apr;7(4):703-8.

5. NEROFE™ - A novel human hormone-peptide with anti-cancer activity

Uziel Sandler, Orly Devary, Ori Braitbard, Joel Ohana, Gideon Kass, Ariel M. Rubinstein, Zeev Y. Friedman and Yoram Devary

Journal of Experimental Therapeutics and Oncology. Volume 8, Number 4, 2010, p. 327-339.

6. Competition between bound and free peptides in an ELISA-based procedure that assays peptides derived from protein digests
Ori Braitbard, Hava Glickstein, Janette Bishara-Shieban, Umberto Pace, Wilfred D. Stein . Proteome Science 2006, 4:12

7. An ELISA-based procedure for assaying proteins in digests of human lymphocytes and cell lines, using specifically chosen peptides and appropriate antibodies

Ori Braitbard, Janette Bishara-Shieban  , Hava Glickstein, Miriam Kott-Gutkowski Umberto Pace  , Deborah G. Rund  and Wilfred D. Stein .

Proteome Science  2006, 4:14

 

PROCEEDING OF MEETINGS

1. Using a Viral Signal Peptide as Vaccine: The Case for Mouse Mammary Tumor Virus.

Ori Braitbard, Maayan Roniger, Dana Raijman, Allan Bar-Sinai and Jacob Hochman .

The 13th International Conference on Progress in Vaccination Against Cancer. Amsterdam, The Netherlands. October 2013

 

2.  A signal peptide as a putative tool against MMTV-associated breast cancers

Ori Braitbard, Maayan Roniger,  Dana Rajchman, Allan Bar-Sinai, Nira Hochman  and Jacob Hochman .

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

San Diego, CA. Oct. 2013

 

3.  ‘Salan’ Titanium(IV) Complexes: A New Class of Anti-Cancer Agents

Braitbard O. ,Meker, S., Stolarov M., Hochman J  and Tshuva E. Y.

The 104nd Annual Meeting of the American Association for Cancer Research, 2013

 

4.Highly Potent Anti-Cancer ‘Salan’ Titanium(IV) Complexes Structure - Function Relationship

S. Meker, O. Braitbard, C. M. Manna1, E. Weiss, E. Y. Tshuva  and J. Hochman

The 103nd Annual Meeting of the American Association for Cancer Research, 2012

 

5. A new class of Titanium compounds as anti-cancer drugs

Ori Braitbard, Cesar M. Manna, Esti Weiss, Jacob Hochman, Edit Y. Tshuva

The third annual meeting of the Israeli Society for Cancer Research,2011

 

6. Cranberry juice constituents as an adjuvant for protein vaccination against malignant lymphoma

Jacob Hochman, Ori Braitbard, Maayan Roniger, Allan Bar-Sinai, Ervin I. Weiss, Nira Hochman

The 102nd Annual Meeting of the American Association for Cancer Research, 2011

 

7. A Novel Human Hormone-Peptide NEROFE™ with Strong anti Cancer Activity

Uziel Sandler, Orly Devary, Ori Braitbard, Joel Ohana, Gideon Kass, Yoram Devary

RECENT ADVANCES in CLINICAL MEDICINE 2010 156-161

The WSEAS Press publishes    

 

8. A Novel Human Hormone-Peptide NEROFE Selectively Induces Apoptosis in Cancer  Cells through the T1/ST2 Receptor

Uziel Sandler, Orly Devary, Ori Braitbard, Ariel M.Rubinstein, Zeev Y. Friedman, Yoram Devary

RECENT ADVANCES in CLINICAL MEDICINE 2010 162-167,The WSEAS Press  

 

9. A Novel Human Cytotoxic Cell Activation Factor with anti-Cancer Activity

Tamara Sandler, Ori Braitbard, Joel Ohana, Gideon Kass, Orly Devary

RECENT ADVANCES in CLINICAL MEDICINE 2010 168-173

The WSEAS Press publishes   

 

10. Reduction of multi-drug resistance from within live cells using the Mab C219 linked to (37-72)Tat

Ori Braitbard , Hans Wellhöner, Aryeh Weiss1, Axel Schulz, Knut Adermann,  Allan Bar-Sinai and Jacob Hochman

Inaugural meeting of the Israeli Society for Cancer,  2009

 

11. Use of MMTV-p14 as a vaccine against MMTV-bearing tumors

Maayan Roniger, Ori Braitbard, Allan Bar-Sinai, Nira Hochman and Jacob Hochman

The 100nd Annual Meeting of the American Association for Cancer Research, 2009.

 

12. Functional dissection of the Mouse Mammary Tumor Virus (MMTV) env-precursor leader sequence (p14) in cancer cells that harbor this         virus. 

Dafna Feldman, Maayan Roniger, Allan Bar-Sinai, Ori Braitbard, Yonat Mordoch, Carmit Natan, Jacob Hochman.

AACR 99nd Annual Meeting 2008.

 

14. A novel ligand - Thymus Expressed Apoptosis Factor induces apoptosis in             cancer cells through T1/ST2 receptor

 Uziel Sandler, Orly Devary, Ori Briatbard, Ariel M. Rubinstine, Zeev Y. Friedman, Yoram Devary

JCT and ISK Ltd, Jerusalem, Israel

 NCRI Cancer Conference, 2007

 

15. The Proteomatrix, a novel tool for cellular protein expression profiling:

            application to proteins involved in resistance to chemotherapy

            Student Lecture Competition,

Ori Braitbard, Hava Glickstein, Janette Bishara-Shieban, Umberto Pace and

Wilfred D. Stein.

ISPP Annual Meeting , 2005

 

16.  The Proteomatrix, a novel tool for cellular protein expression profiling:     application     to proteins involved in resistance to chemotherapy

Wilfred D. Stein, Ori Braitbard, Hava Glickstein, Janette Bishara, Umberto Pace. (2003)

AACR 95nd Annual Meeting,  2003.